World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , 

World Journal of Pharmaceutical
and Medical Research

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 4.639

ICV : 78.6

Abstract

SOFOSBUVIR, THE NUCLEOTIDE ANALOGUE AGAINST HEPATITIS C VIRUS – A REVIEW

Soumya S. P.*, Sinchu Yesudanam, Anusree S., Dr. William Arputha Sundar A. S. and Sam Jeeva Kumar E.

ABSTRACT

Infectious liver disease caused by the hepatitis C virus. There is no vaccine and it commonly becomes chronic. Traditional treatment is limited by frequent adverse effects and low efficacy. The current therapy for HCV infection, includes one of the two protease inhibitors, telaprevir or boceprevir, for 12-32 weeks with pegylated interferone interferon alfa-2a (PEG-IFN-?) and ribavirin for 48 weeks. Sofosbuvir, a recently approved nucleotide analog, is a highly potent inhibitor of the NS5B polymerase in the Hepatitis C virus (HCV), and has shown efficacy in combination with several other drugs, with and without PEG-INF, against HCV. It offers many advantages due to its high potency, low side effects, oral administration, and high barrier to resistance.

[Full Text Article]

Powered By WJPMR | All Right Reserved

WJPMR